These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9323717)

  • 1. Gene therapy for retinal degeneration.
    Reichel MB; Ali RR; Hunt DM; Bhattacharya SS
    Ophthalmic Res; 1997; 29(5):261-8. PubMed ID: 9323717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation.
    Bok D; Yasumura D; Matthes MT; Ruiz A; Duncan JL; Chappelow AV; Zolutukhin S; Hauswirth W; LaVail MM
    Exp Eye Res; 2002 Jun; 74(6):719-35. PubMed ID: 12126945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration.
    Rex TS; Allocca M; Domenici L; Surace EM; Maguire AM; Lyubarsky A; Cellerino A; Bennett J; Auricchio A
    Mol Ther; 2004 Nov; 10(5):855-61. PubMed ID: 15509503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is successful gene therapy for retinal disease in sight?
    Caplen NJ
    Mol Med Today; 2000 Sep; 6(9):340. PubMed ID: 11202971
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of neuronal visual responses in the superior colliculus in Prph2(Rd2/Rd2) mice following gene therapy.
    Schlichtenbrede FC; Smith AJ; Bainbridge JW; Thrasher AJ; Salt TE; Ali RR
    Mol Cell Neurosci; 2004 Jan; 25(1):103-10. PubMed ID: 14962744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration.
    Buch PK; MacLaren RE; Durán Y; Balaggan KS; MacNeil A; Schlichtenbrede FC; Smith AJ; Ali RR
    Mol Ther; 2006 Nov; 14(5):700-9. PubMed ID: 16872907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of retinal degenerations: RPE65, ABCA4, RDS, and bicarbonate transporter genes as examples.
    Bok D
    Retina; 2005 Dec; 25(8 Suppl):S18-S20. PubMed ID: 16374319
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.
    Colella P; Iodice C; Di Vicino U; Annunziata I; Surace EM; Auricchio A
    Hum Mol Genet; 2011 Jun; 20(11):2251-62. PubMed ID: 21421996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy.
    Schlichtenbrede FC; da Cruz L; Stephens C; Smith AJ; Georgiadis A; Thrasher AJ; Bainbridge JW; Seeliger MW; Ali RR
    J Gene Med; 2003 Sep; 5(9):757-64. PubMed ID: 12950066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated knockdown of peripherin-2 in vivo using miRNA-based hairpins.
    Georgiadis A; Tschernutter M; Bainbridge JW; Robbie SJ; McIntosh J; Nathwani AC; Smith AJ; Ali RR
    Gene Ther; 2010 Apr; 17(4):486-93. PubMed ID: 20010626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of modeling macular degeneration in mice.
    Marmorstein AD; Marmorstein LY
    Trends Genet; 2007 May; 23(5):225-31. PubMed ID: 17368622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular gene delivery of ciliary neurotrophic factor results in significant loss of retinal function in normal mice and in the Prph2Rd2/Rd2 model of retinal degeneration.
    Schlichtenbrede FC; MacNeil A; Bainbridge JW; Tschernutter M; Thrasher AJ; Smith AJ; Ali RR
    Gene Ther; 2003 Mar; 10(6):523-7. PubMed ID: 12621456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy in inherited retinal degenerative diseases, a review.
    Takahashi VKL; Takiuti JT; Jauregui R; Tsang SH
    Ophthalmic Genet; 2018 Oct; 39(5):560-568. PubMed ID: 30040511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of visual functions.
    Deeb SS
    Curr Opin Neurobiol; 1993 Aug; 3(4):506-12. PubMed ID: 8219717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Therapy for Retinal Degeneration.
    Apte RS
    Cell; 2018 Mar; 173(1):5. PubMed ID: 29570997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary macular dystrophies].
    Rozet JM; Gerber S; Ducroq D; Hamel C; Dufier JL; Kaplan J
    J Fr Ophtalmol; 2005 Jan; 28(1):113-24. PubMed ID: 15767907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the genetics of macular dystrophies.
    Mah DY; Wong PW; Edwards A; MacDonald IM
    Can J Ophthalmol; 1998 Apr; 33(3):135-43. PubMed ID: 9606569
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression.
    Nour M; Ding XQ; Stricker H; Fliesler SJ; Naash MI
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2514-21. PubMed ID: 15277471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular testing for hereditary retinal disease as part of clinical care.
    Downs K; Zacks DN; Caruso R; Karoukis AJ; Branham K; Yashar BM; Haimann MH; Trzupek K; Meltzer M; Blain D; Richards JE; Weleber RG; Heckenlively JR; Sieving PA; Ayyagari R
    Arch Ophthalmol; 2007 Feb; 125(2):252-8. PubMed ID: 17296903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of inherited retinal degenerations: prospects and challenges.
    Trapani I; Banfi S; Simonelli F; Surace EM; Auricchio A
    Hum Gene Ther; 2015 Apr; 26(4):193-200. PubMed ID: 25762209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.